Arrayit Corporation was a biotechnology company focused on microarray technology and related genomic analysis products. Its offerings historically included DNA and protein microarrays, microarray manufacturing equipment, laboratory consumables, software, and testing services for research, pharmaceutical, biotechnology, and diagnostic applications.
The company also developed clinical testing services, including allergy-related testing, and marketed its technology for applications such as gene expression analysis, biomarker discovery, disease research, and personalized medicine. Arrayit served customers in the United States and internationally through direct sales, laboratory services, and commercial partnerships.
Arrayit was founded and led for many years by Mark Schena, who served as president. Publicly available information indicates that the company’s operations and regulatory reporting became substantially limited in the early 2020s; consequently, current information about its products, leadership, and geographic activities is limited.
AI Generated. May Contain Errors.
Free ARYC Stock Alerts